K V Clinical Research Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Net Worth 1562.49%
- Total Assets 3115.51%
About K V Clinical Research
K V Clinical Research Private Limited (KVCRPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 08 October 2020 (Four years and four months 17 days old ). Its registered office is in Raipur, Chattisgarh, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kirti Patel and Vikas Chandrakar serve as directors at the Company.
Company Details
- Location
Raipur, Chattisgarh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U73200CT2020PTC010704
- Company No.
010704
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Oct 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chhattisgarh
Industry
Who are the key members and board of directors at K V Clinical Research?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kirti Patel  | Director | 08-Oct-2020 | Current |
| Vikas Chandrakar | Director | 08-Oct-2020 | Current |
Financial Performance of K V Clinical Research.
K V Clinical Research Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 1562.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of K V Clinical Research?
Unlock access to K V Clinical Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Kventia Therapeutic Private LimitedKirti Patel and Vikas Chandrakar are mutual person
Moxieheal FoundationKirti Patel and Vikas Chandrakar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at K V Clinical Research?
K V Clinical Research has a workforce of 17 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of K V Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped K V Clinical Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.